Vaccine Therapy in Treating Patients With Liver Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

December 31, 2004

Study Completion Date

October 31, 2008

Conditions
Liver Cancer
Interventions
BIOLOGICAL

AFP

Increasing doses of AFP will be given to groups of 3 intradermally. Subjects will receive 3 biweekly vaccinations. At least 2 patients at a given dose must have received their complete 3 vaccination schedule with a 30 day observation period after the last vaccination before a higher dose is initiated.

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00022334 - Vaccine Therapy in Treating Patients With Liver Cancer | Biotech Hunter | Biotech Hunter